The substantial weight reduction observed with tirzepatide monotherapy (15-21% body weight in clinical trials) suggests that any perceived benefits likely reflect tirzepatide's pharmacological effects rather than synergistic action
It may also help with the anxiety of taking the injection
This is clinically relevant because obesity itself is associated with numerous health conditions that might influence treatment tolerance, including metabolic syndrome, cardiovascular disease, sleep apnea, and hepatic steatosis
Sharper focus
Pricing for B12 injections varies depending on the frequency and dosage
Reported Research Benefits Used in preclinical research focused on obesity, metabolic syndrome, diabetes, aging-related metabolic decline, fat mass reduction, and muscle preservation during caloric deficit